Related Experiment Video
Updated: Nov 29, 2025

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
Published on: August 26, 2025
Long-Term Outcomes of Endovascular Interventions in More than 500 patients with Budd-Chiari Syndrome
Naren Hemachandran1, Shalimar2, Subrat Acharya2
1Department of Radiodiagnosis, All India Institute of Medical Sciences, Room no. 81b, Ansari Nagar, New Delhi 110029, India.
Insights
Endovascular interventions for Budd-Chiari syndrome (BCS) demonstrate high technical success and safety. These procedures offer excellent long-term patency and survival rates for patients with BCS.
Area of Science:
- Interventional Radiology
- Hepatology
- Vascular Surgery
Background:
- Budd-Chiari syndrome (BCS) is a rare condition characterized by hepatic venous outflow obstruction.
- Effective long-term management strategies for BCS are crucial for improving patient outcomes.
Purpose of the Study:
- To evaluate and compare the long-term efficacy of diverse endovascular interventions in patients diagnosed with Budd-Chiari syndrome.
- To analyze technical success, clinical outcomes, patency rates, complications, and survival following endovascular treatment for BCS.
Main Methods:
- A single-center retrospective analysis included 510 consecutive patients with BCS undergoing 618 endovascular procedures (January 2001-December 2019).
- Interventions comprised recanalization (angioplasty/stenting) and transjugular intrahepatic portosystemic shunt (TIPS) creation.
- Data collected included technical success, clinical success, patency, complications, and survival rates.
Main Results:
- Overall technical success rate was 96%. Recanalization procedures were performed in 71% and TIPS in 29% of patients.
- Major complications occurred in 2.8% of cases. Vascular/stent restenosis was observed in 19%, with successful reintervention in 86.3%.
- One- and 5-year cumulative patency rates were 87%/74% (recanalization) and 95%/68% (TIPS). One- and 5-year survival rates were 96%/89% (recanalization) and 90%/76% (TIPS).
Conclusions:
- Endovascular interventions are a feasible and safe treatment modality for the majority of patients with Budd-Chiari syndrome.
- These procedures yield excellent short- and long-term patency and survival rates, underscoring their therapeutic value in managing BCS.
Purpose:
To assess and compare the long-term outcomes of various endovascular interventions in patients with Budd-Chiari syndrome (BCS).
Materials And Methods:
In this single-center retrospective study, 510 consecutive patients with BCS who had undergone a total of 618 endovascular procedures from January 2001 to December 2019 were included. Details of the type of endovascular intervention, technical success, clinical success, patency rate, complications, and survival outcomes were analyzed.
Results:
The overall technical success rate was 96% (593 of 618 procedures; 500 in treatment-naïve patients and 93 repeat interventions for recurrent disease). Endovascular procedures included recanalization procedures (angioplasty and stent placement) in 355 patients (71%) and transjugular intrahepatic portosystemic shunt (TIPS) creation in 145 (29%). Major postprocedure complications occurred in 14 patients (2.8%). Vascular/stent restenosis occurred in 95 patients (19%), and successful repeat intervention was performed in 82 of those 95 (86.3%). An additional 11 of these 82 (13.4%) underwent a third intervention for restenosis. In the recanalization and TIPS groups, the 1- and 5-y cumulative patency rates were 87% and 74% and 95% and 68%, respectively. The 1- and 5-y survival rates were 96% and 89% and 90% and 76%, respectively.
Conclusions:
Endovascular interventions for BCS are feasible and safe in the majority of patients, with excellent short- and long-term patency and survival rates.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Varicose Veins II: Diagnostic Studies and Interprofessional Care
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
